Regulatory & Legal

Investor NHGGP proposes a JPY36B share repurchase, arguing the Maruchan noodle giant's massive cash pile is depressing its value despite global success.

The owner of Men's Wearhouse confidentially files for an IPO, signaling a major comeback after its 2020 bankruptcy. What's behind the strategic move?

VSI surgeons performed the world's first spine surgery with an AI-powered robotic system, promising a new era of surgical precision and patient safety.

The advanced materials firm plans a SPAC merger to scale its 'Atomic Armor' nanocoating, aiming to secure U.S. tech sovereignty in AI and defense.

Federal regulators warn of deadly, shrapnel-spraying counterfeit airbags. Learn the signs that your vehicle could be at risk and how to protect yourself.

A beloved Illinois golf course is getting a new lease on life, blending recreation with renewable energy in a groundbreaking new partnership.

The private jet firm reports impressive top-line growth, but SEC filings reveal widening losses and raise serious questions about its path to profitability.

As GPS fails in modern warzones, one company's software-only solution allows drones to navigate and target without it, changing the face of conflict.

New leadership at the National Hemp Association and HEMI signals a unified push to untangle federal policy and launch a 'Got Milk?'-style campaign.

A controversial bill heads for a final vote in South Carolina, threatening to shutter wellness shops and funnel CBD sales through liquor stores.

S&P Global Energy and the UN SSE are launching a major partnership to equip global stock exchanges with the data needed to unlock trillions in green finance.

AI chat platform Reverie challenges rivals with conversation forking, multi-character worlds, and a new creator economy for the booming NSFW AI market.

A landmark ruling strikes down a punitive IRS rule, removing the "tax shelter" label from micro captive insurance and boosting small business risk management.

Celebrating its 1,000th fellow, a visionary program empowers women in STEM to drive change, from cancer tech to national policy, in their home countries.

As millions seek alternatives to traditional sleep pills, cannabis products are taking over. A #1 ranked gummy reveals the science and trends behind the shift.

The senior care provider celebrates a major workplace culture award, but does the official certification tell the whole story for its fast-growing workforce?

ABD Group's new €500M+ deal, backed by Washington, deepens its 15-year commitment and aims to fuel Côte d'Ivoire's ambitious national development plan.

Obsidian Therapeutics will unveil pivotal Phase 2 data on OBX-115, an engineered cell therapy that may offer a safer, more potent weapon against melanoma.

Amid a surge in Canadian infrastructure and housing, Rimkus appoints key executives to lead its expansion and tackle complex climate-resilient building challenges.

Biotech firm Northwest Biotherapeutics is opening a private clinic to speed up cancer therapy access, a strategic move to control its supply chain.